Published on 7 Mar 2024 on Zacks via Yahoo Finance
Silk Road Medical's (SILK) New Stent Expands Its TCAR Portfolio
Silk Road Medical, Inc. SILK recently announced the launch of its Tapered ENROUTE Transcarotid Stent System in the United States, which is indicated for patients at high risk and standard risk for adverse events from carotid endarterectomy (CEA).
With the recent launch, the company builds on its previous ENROUTE Transcarotid Stent System, providing more configuration options to better fit patient anatomy and facilitate Transcarotid Artery Revascularization (TCAR).
Price Performance